Nov 20, 2024, 20:27 | Insight

HIPEC improves overall survival in recurrent epithelial ovarian cancer

Pramesh CS, Director at Tata Memorial Hospital, shared a recent article by Jean-Marc Classe on…

Nov 19, 2024, 20:55 | Blog

Rawia Mohamed: Updates and Insights on MMR in Colorectal Cancer

Rawia Mohamed, Head of the Anatomical Pathology Department at Burjeel Medical City, shared a post…

Nov 19, 2024, 20:45 | Insight

Pharmacogenomic predictors of common chemotherapy toxicities by Ivone U.S. Leong

Maryam Lustberg, Director of the Center for Breast Cancer at Yale Cancer Center, shared a…

Nov 16, 2024, 15:52 | Insight

Lucjan Wyrwicz: Immunotherapy in cancer is a story of success

Lucjan Wyrwicz, Head of Department, Dept. of Oncology and Radiotherapy at Maria Skłodowska-Curie Memorial Cancer…

Nov 16, 2024, 09:57 | Blog

Targeting expression in metastatic breast cancer - ASCO

ASCO posted the following on X: “Though ADCs have emerged as a cutting-edge approach to…

Nov 14, 2024, 14:40 | Dialogues

Advances in Head and Neck Cancer with Dr. Paolo Bossi | OncoInfluencers

In this episode of OncoDaily, Dr. Paolo Bossi, Associate Professor of Oncology at Humanitas University,…

Nov 14, 2024, 11:38 | Blog

Amol Akhade: Seeking insights on DYPD mutation testing in cancer treatment

Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post…

Nov 13, 2024, 09:11 | Blog

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a recent article by…

Nov 13, 2024, 07:41 | Insight

Key Factors in Menstrual Recovery for Pre-menopausal Breast Cancer on Tamoxifen

Matteo Lambertini, Associate Professor at the University of Genoa and Medical Oncologist at San Martino…

Nov 11, 2024, 17:58 | Blog

COVID-19 Severity and Cancer Therapy

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a paper by Petros Grivas…

Nov 10, 2024, 19:34 | Cancer Types,Oncolibrary

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Pancreatic cancer is a malignant disease that originates in the tissues of the pancreas, an…

Nov 10, 2024, 02:00 | Insight

Nelson Dusetti: The applicability of our signatures in predicting treatment sensitivity and resistance in PDAC patients

Nelson Dusetti, Scientific Director of the company Predicting Med(CSO) and Chair of TRANSLATE-IT CRCM, shared an…

Nov 9, 2024, 20:08 | Blog

Dr. Sara Tolaney Discusses ESMO24 Insights on TroFuse-010 Trial in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center shared the following on X: “Dr. Sara Tolaney discussed ESMO24 Insights…

Nov 9, 2024, 13:59 | Blog

Wafik S. El-Deiry: Dr. Graham Walker on targeting translesion synthesis to overcome chemotherapy

Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and…

Nov 9, 2024, 12:35 | Blog

Amol Akhade: The choice of chemotherapy regimen for metastatic pancreatic cancer patients

Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post…

Nov 8, 2024, 14:27 | Dialogues

ASCO24 Updates - Dr. Mohammad Jad Moussa on Small Cell Bladder Cancer: Relapse Risks and pCR Impact

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Nov 5, 2024, 11:12 | Insight

Cathy Eng: Role of ctDNA in resected liver metastasis in colorectal cancer by Koshi Kataoka et. al

Cathy Eng, Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center, posted…

Nov 5, 2024, 05:47 | Opinion

Kamala Harris vs Donald Trump on Cancer: From Cancer Moonshot to Right to Act, Funding, Research and Future

Cancer remains one of the most pressing health challenges of our time, affecting millions of…

Nov 4, 2024, 15:31 | Insight

Do patients with small ER+ tumors with high genomic risk benefit from chemotherapy?

An article by Florentine Hilbers, Postdoctoral Researcher at The Netherlands Cancer Institute, was recently mentioned by…

Nov 3, 2024, 15:49 | Blog

Paolo Cotzia: Investigating the role of immunotherapy in metastatic inflammatory breast cancer

Paolo Cotzia, Medical Director of Molecular Pathology and Head of Molecular Excellence at Sonic Healthcare…

Nov 3, 2024, 11:54 | Dialogues

Zolbetuximab: From Promising Drug to FDA Approval | Exclusive Interview with Astellas

In this episode of OncoDaily, Dr. Moitreyee Chatterjee-Kishore and Tomoko Nakajima from Astellas Pharma join…

Nov 2, 2024, 12:01 | Positive

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…

Nov 2, 2024, 03:25 | Blog

Chemotherapy Outcomes in Pregnant Breast Cancer Patients - ACS Journal Cancer

ACS Journal Cancer shared the following on X: “New! Women treated for breast cancer during…

Nov 1, 2024, 07:37 | Blog

Paolo Tarantino: ADCs combine the potency of chemotherapy with the PK of mAbs

Paolo Tarantino, Fellow at Dana-Farber Cancer Institute, shared a post on X: "ADCs combine the potency…

Nov 1, 2024, 01:53 | Insight

Cihangir Akyol: Age is not a barrier to colorectal cancer survival

Cihangir Akyol, Professor of Surgery at Ankara University, shared his recent article on X: "Age is not…

Oct 31, 2024, 13:04 | Blog

Megan-Claire Chase: No one goes through cancer unscathed

Megan-Claire Chase, Director of SHARE Cancer Support and Patient Advocate, shared this post on LinkedIn:…

Oct 31, 2024, 10:10 | Insight

Evaluating the Efficacy of Scalp Cooling on Hair Loss in Patients with Metastatic Breast Cancer: A Phase II Clinical Trial

We are pleased to announce the enrollment of participants for a pivotal Phase II clinical…

Oct 30, 2024, 16:04 | Blog

Richard Paxman: Raising Awareness of PCIA for Breast Cancer Awareness Month

Richard Paxman, Chief Medical Officer and Managing Director at Paxman, posted the following on LinkedIn:…

Oct 29, 2024, 17:57 | Insight

Beverly A. Zavaleta: Mouth Sores and Cancer Treatment Survey

Beverly A. Zavaleta, Physician Advisor at Tenet Healthcare, shared a post on X: “If you…

Oct 29, 2024, 15:42 | Blog

Megan-Claire Chase: No one goes through cancer unscathed

Megan-Claire Chase, Breast Cancer Program Director at Share Cancer Support, shared on LinkedIn: "Though this is…

Oct 29, 2024, 10:05 | Insight

Tips to prevent and reduce side effects on Braving Chemo by Beverly A. Zavaleta

Beverly A. Zavaleta, Physician Advisor at Tenet Healthcare, shared on X: “BIG thank you to…

Oct 28, 2024, 09:26 | Blog

Maryam Lustberg: A new multi PI R01 for patients living with chemotherapy induced neuropathy

Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital, shared a…

Oct 27, 2024, 20:06 | Blog

The Role of Lifestyle Modification in Enhancing Cancer Therapy Outcomes

Akash Maniam, Medical oncologist at Portsmouth Hospitals University NHS Trust, shared on Linkedin: ''Quite a…

Oct 26, 2024, 12:49 | Insight

Gustavo Viani: No Difference in Coronary artery disease Risk for Left- vs. Right-Sided Breast Cancer Treatment

Gustavo Viani, Associate Professor at the University of São Paulo, shared on LinkedIn: “Modern Radiotherapy…

Oct 26, 2024, 11:17 | Blog

Chandandeep Kaur: Advances in Preventing Chemotherapy-Induced Hair Loss

Chandandeep Kaur, Scientific Writer/Consultant at Happiest Health shared a post on LinkedIn: "Advances in Preventing…

Oct 25, 2024, 02:00 | Dialogues

ASCO24 Updates: Dr. Filippo Pietrantonio on ARMANI Trial Findings for Advanced Gastric Cancer

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 24, 2024, 20:14 | Blog

Suhail Qureshi explains how scalp cooling works

Chandandeep Kaur, Science Writer and Consultant at Happiest Health, shared a post on X: ''Suhail…

Oct 24, 2024, 17:41 | Blog

Sami (Papacek) Mansfield: October is almost over but breast cancer awareness must continue

Sami (Papacek) Mansfield, Founder of Cancer Wellness for Life, shared a post by Total Health Oncology on…

Oct 23, 2024, 14:45 | Blog

Paolo Tarantino: How do we build a new generation of safer and more active ADCs for treating cancer

Paolo Tarantino and Raffaele Colombo shared posts on X, about recent paper published in Cancer…

Oct 23, 2024, 10:00 | Insight

MD Anderson Research Highlights

Featuring novel targets for breast cancer, epigenetic strategies to improve immune responses, a treatment for…

Oct 22, 2024, 15:58 | Blog

Anirban Maitra: Revolution Medicines has launched its phase 3 study of RMC-6236

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…

Oct 22, 2024, 14:46 | Blog

Michelle Mitchell: Reflecting on CRUK's impact for people affected by cancer

Michelle Mitchell shared on Linkedin: ''I’ve spent the last couple of days in Birmingham with…

Oct 22, 2024, 11:52 | Blog

Anand Patel: Interesting article on adults over sixty years old with CBF-AML treated with intensive chemotherapy

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…

Oct 21, 2024, 08:33 | Blog

Supriya Mohile: Challenges in chemotherapy outcomes for older adults

Supriya Mohile shared the following on X: “Dr. Zhihong Zhang (Sandy) reports that only 18…

Oct 20, 2024, 18:22 | Blog

Day 2 of the CCI Conference - Childhood Cancer International Europe

Childhood Cancer International - Europe shared the following on LinkedIn: “Commencing Day 2 of the…

Oct 20, 2024, 17:10 | Blog

Omnia Korani: Pembrolizumab plus chemotherapy did not improve DFS in high-risk endometrial cancer

Omnia Korani, Assistant Lecturer at the National Cancer Institute, shared a post on LinkedIn: “Adjuvant…

Oct 20, 2024, 13:37 | Dialogues

ASCO24 Updates: Andres Marmol-Perez on Sarcopenia in Childhood Cancer Survivors

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 20, 2024, 12:48 | Insight

Reza Ghalehtaki: TNT is the new standard of care for LARC

Reza Ghalehtaki, Radiation Oncologist at Cancer Institue of Iran, shared a post on X: "Hot…

Oct 20, 2024, 11:38 | Blog

Maryam Lustberg: How minocycline Affects Cognition and Inflammation in Breast Cancer Survivors on Chemotherapy

Maryam Lustberg shared a post on Linkedin: ''Neuroinflammation from chemotherapy andover activated Microglia contribute to…

Oct 18, 2024, 14:42 | Blog

Paxman Scalp Cooling - Discussing Chemotherapy Induced Alopecia at Strength Early Onset Breast Cancer Conference

Paxman Scalp Cooling shared on Linkedin: ''This weekend, Jacqueline Olsen from our US team joined the…

Oct 17, 2024, 17:51 | Blog

Shahrin Ahmed: Liver Cancer Awareness Month

Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, shared a post on X: ''Liver Cancer…

Oct 17, 2024, 16:20 | Insight

Aaron Goodman: One of my favorite differentials, Intestinal T/NK lymphoma

Aaron Goodman, Associate Professor of Medicine at the University of California, San Diego, shared a…

Oct 17, 2024, 12:57 | Insight

Antonio Calles: Massive news for patients with SCLC

Antonio Calles, Medical Specialist in Medical Oncology at Gregorio Marañón General University Hospital, shared a…

Oct 16, 2024, 13:33 | Blog

The importance of skeletal muscle in the outcomes of our individuals with cancer, with the new direction of immunotherapy and CAR T-cell therapy

Sami (Papacek) Mansfield, is the founder of Cancer Wellness for Life shared a post by…

Oct 15, 2024, 12:59 | Blog

Brendon Stiles: We owe it to our patients with EGFR mutations

Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology, Montefiore Health System shared a post on…

Oct 14, 2024, 10:30 | Insight

MHRA Approves Merck and Astellas/Pfizer's Bladder Cancer Combination Therapy

The MHRA has approved the combination of Keytruda (pembrolizumab) and Padcev (enfortumab vedotin) as a…

Oct 12, 2024, 22:16 | Insight

Triparna Sen: CD38-mediated immunosuppression as a potential mechanism of tumor cell escape from PDL1 inhibition in SCLC

Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on…

Oct 12, 2024, 10:30 | Insight

FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer

On October 10, 2024, the FDA approved inavolisib (Itovebi, Genentech, Inc.) in combination with palbociclib…

Oct 11, 2024, 16:52 | Blog

Nikolina Dodlek: Improving the quality of life and manage side effects of chemotherapy with Virtual Reality

Nikolina Dodlek, Cancer Nurse, UnitedHealthcare, Osijek, shared a post on X: "f you are (AYA)…

Oct 11, 2024, 13:58 | Blog

Francesco Massari: Global real-world experience in mUC treatment

Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, posted…

Oct 10, 2024, 16:36 | Blog

Jenna Fischer opens up about her brave battle with breast cancer

Jenna Fischer, the beloved actress known for her iconic role as Pam Beesly on the…

Oct 9, 2024, 10:29 | Blog

Shushan Hovsepyan: Finally got my hands on the wonderful book Nella Terra di Mezzo

Shushan Hovsepyan posted the following on LinkedIn: “Yesterday I finally got my hands on the…

Oct 8, 2024, 15:29 | Insight

Jarushka Naidoo: Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab in NSCLC

Jarushka Naidoo shared a post on X: “Long-Term Outcomes 1L Ipilimumab/Nivolumab/-Chemo v Chemo in PDL1<1%…

Oct 8, 2024, 12:47 | Insight

Intrinsic temperature increases ferroptosis evasion and chemotherapy resistance in Pancreatic Cancer, suggested by Anirban Maitra

Anirban Maitra shared a post on X: "Fascinating! Intrinsic temperature increase drives lipid metabolism towards ferroptosis…

Oct 7, 2024, 11:35 | Blog

Carla Tardif: Children with cancer from low-income households are three times more likely to die and two times more likely to relapse than their counterparts

Carla Tardif shared a post on LinkedIn, about recent article published on her LinkedIn: ''Parents…

Oct 6, 2024, 14:01 | Insight

MD Anderson Research Highlights

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…

Oct 4, 2024, 15:09 | Blog

Phase 3 EVER-002 trial is out

Paolo Tarantino shared an article by Binghe Xu on X: "Phase 3 EVER-002 trial (also…

Oct 4, 2024, 15:04 | Insight

Yakup Ergün: Curative ICIs therapy in patients with dMMR locally advanced rectal cancer

Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X: “Curative ICIs therapy in patients…

Oct 4, 2024, 06:03 | Drugs

FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC

FDA Approval Introduces New Treatment Options for Adults with Resectable Lung Cancer Lacking Key Genetic…

Oct 2, 2024, 13:22 | Blog

The results of the TOPGEAR trial on gastric and GEJ adenocarcinoma - EORTC

EORTC (European Organisation for Research and Treatment of Cancer) shared a post on LinkedIn: ''We’re…

Oct 2, 2024, 13:06 | Blog

What is the difference between chemotherapy and immunotherapy - CRI

CRI (Cancer Research Institute) shared a post on LinkedIn: ''What is the difference between chemotherapy…

Oct 2, 2024, 10:28 | Blog

Justin Stebbing: How to deal with chemotherapy side effects

Justin Stebbing shared at theconversation.com: "Chemotherapy is powerful cancer medication – but it can also…

Oct 1, 2024, 15:49 | Insight

Shankar Siva: QoL outcomes in the adaptive radiotherapy SPRINT PET trial

Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, shared on X: “ASTRO24 -…

Sep 30, 2024, 16:54 | Insight

Tom Powles: 1st perioperative immune therapy study to show an OS in bladder cancer

Tom Powles shared an article on X: "Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder…

Sep 28, 2024, 16:31 | Blog

Dr. Anna Lasorella discusses innovative cancer treatments - Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared the following on LinkedIn: “Dr. Anna Lasorella, co-director of the…

Sep 28, 2024, 14:55 | Dialogues

ASCO24 Updates: Dr. Iris Zhi on Acupuncture and Integrative Medicine for Chemotherapy-Induced Neuropathy

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Sep 27, 2024, 16:52 | Blog

Maryam Lustberg: Virtual support for breast cancer patients starting neoadjuvant therapy

Maryam Lustberg shared the following on LinkedIn: “Many patients look for dietary support and counseling…

Sep 27, 2024, 16:31 | Insight

Immunotherapy for aggressive breast cancer appears to be effective even without chemotherapy - The Netherlands Cancer Institute

The Netherlands Cancer Institute posted on LinkedIn: "Immunotherapy as a treatment for an aggressive form of…

Sep 27, 2024, 14:43 | Dialogues

ASCO24 Updates: Dr. Junaid Arshad - Tadalafil and New Approaches to Gastric Cancer

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Sep 26, 2024, 15:41 | Blog

Mark Lewis: The 'trolley problem' of adjuvant chemotherapy in colon cancer

Mark Lewis shared a post on X, about paper published in Journal of Clinical Oncology:…

Sep 26, 2024, 15:37 | Blog

Stephen V Liu: Retrospective report on treatment post osimertinib for EGFR NSCLC

Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…

Sep 26, 2024, 15:30 | Dialogues

ASCO24 Updates - Dr. Fuming Qiu on NewScore Trial: Neoadjuvant Chemotherapy and Biomarker Insights

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Sep 26, 2024, 14:07 | Blog

Paolo Tarantino: Why didn’t Datopotamab Deruxtecan improve OS in HR+/HER2- metastatic breast cancer

Paolo Tarantino shared a post on X: ''Why didn’t Datopotamab Deruxtecan improve overall survival in hormone…

Sep 26, 2024, 12:37 | Insight

Exclusive Interview With Fred Saad

MediaMedic shared on LinkedIn: “Exclusive Insights on mHSPC Treatment: Interview with Fred Saad. In a…

Sep 26, 2024, 12:10 | Celebrities

Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More

Jeff Bridges, the Academy Award-winning actor best known for his roles in "The Big Lebowski"…

Sep 26, 2024, 10:16 | Dialogues

ASCO24 Updates - Jordi Ramon on EGFR-Mutant Lung Cancer: Targeted Therapy and Resistance Strategies

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Sep 26, 2024, 09:30 | Insight

Erman Akkus: Neoadjuvant CRT vs. ChT for initially unresectable locally advanced ‘Colon’ cancer

Erman Akkus posted on X: “Neoadjuvant CRT vs. ChT for initially unresectable locally advanced ‘Colon’…

Sep 25, 2024, 18:29 | Insight

Tanja Obradovic: Ligufalimab plus ivonescimab combined with chemo in the first-line CRC patients

Tanja Obradovic shared a post on LinkedIn: "Tackling large medical need in microsatellite stable (MSS)…

Sep 25, 2024, 16:31 | Blog

Elisa Agostinetto: Datopotamab-Deruxtecan in HR+/HER2-low or negative metastatic breast cancer

Elisa Agostinetto shared a post on X: ''A press release from industry announces that TROPION-Breast01…

Sep 25, 2024, 16:28 | Opinion

Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance

Raffaele Colombo shared on X: “Datopotamab deruxtecan (Dato-DXd) in TROPION-Breast01 did not achieve statistical significance…

Sep 25, 2024, 13:30 | Blog

Matteo Dugo: Neoadjuvant atezolizumab plus chemotherapy in TNBC

Matteo Dugo shared a post on LinkedIn, about recent paper published in Clinical Cancer Research:…

Sep 24, 2024, 12:50 | Dialogues

60 +1 Questions About Acute Lymphoblastic Leukemia in Children with Scott Howard

Professor Scott Howard is the Deputy Director at Yeolyan Hematology and Oncology Centerand the CEO…

Sep 24, 2024, 11:04 | Blog

Stephen V Liu: The recent FDA approval of the MARIPOSA-2 regimen for EGFR NSCLC

Stephen V Liu shared a post on X: ''In this episode of the IASLC podcast…

Sep 21, 2024, 14:54 | Blog

Lacy Hubbard: Wrapping up an unforgettable final day at the World Cancer Congress

Lacy Hubbard shared a post on LinkedIn: "Wrapping up an unforgettable final day at the…

Sep 21, 2024, 13:07 | Blog

Olubukola Ayodele about HER2 low breast cancer

Olubukola Ayodele shared a post on LinkedIn: ''Let's talk about HER2 low breast cancer. The…

Sep 21, 2024, 01:25 | Insight

Paolo Tarantino: 10 facts to know to prepare for the rise of ADCs

Paolo Tarantino shared on X: “ADCs are among the most rapidly expanding treatment modalities in…

Sep 19, 2024, 15:54 | Drugs

Innovative Cancer Treatment: Platinum-Based Drugs and Immunotherapy

Maria Babak shared a post by The Babak Lab on LinkedIn: “This research sheds light…

Sep 19, 2024, 12:29 | Celebrities

Val Kilmer and Throat Cancer: How He Went Against, Survived and More

Val Kilmer is an American actor known for his versatile roles in film and theater.…

Sep 16, 2024, 15:00 | Insight

Insights from ESMO24 Day 3

The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…

Sep 14, 2024, 15:38 | Insight

ESMO24 Day 1 highlights by Tom Powles

The ESMO Congress 2024 (ESMO24) is taking place from 13-17 September 2024, in Barcelona. ESMO24…